Complement-Based Drug Development Summit leaderboard
  • Wednesday, October 14, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 479

SciBite launches state-of-the-art AI platform for Life Sciences organisations

Sep 9, 2020
SciBite, the award-winning semantic technology company, announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning…
Read More...

Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to…

Sep 9, 2020
Exelixis, Inc. and NBE-Therapeutics announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) for oncology applications by leveraging NBE’s unique…
Read More...

AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA…

Sep 9, 2020
AnGes, Inc. announced a collaboration agreement with Brickell Biotech, Inc. a clinical-stage pharmaceutical company, through which Brickell has the right to develop AnGes’ proprietary…
Read More...

Mylan to Acquire Aspen’s Thrombosis Business in Europe

Sep 9, 2020
Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR…
Read More...

Immune Regulation Ltd Receives Notice of Allowance for New U.S. Patent for its Novel Protein with…

Sep 8, 2020
Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for…
Read More...

AnHeart Licenses Two Clinical Stage Oncology Candidates from Daiichi Sankyo

Sep 8, 2020
AnHeart Therapeutics, Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, has through its subsidiary AnHeart Therapeutics Inc. entered into…
Read More...

Grifols to acquire Alkahest for $146m

Sep 8, 2020
Grifols announced it has entered into a transaction to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. No additional…
Read More...

Destiny Pharma and SporeGen announce collaboration and Innovate UK grant award to co-develop novel,…

Sep 8, 2020
Destiny Pharma plc, a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of…
Read More...

IcanoMAB GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in…

Sep 7, 2020
IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision canonical antibodies for the treatment of cancer, immune-system…
Read More...

HEUFT to host a free exclusive webinar on Pulsed x-ray technology & smart optics for a total…

Sep 7, 2020
SMi reports: HEUFT to host a free exclusive webinar Pulsed x-ray technology & smart optics for a total inspection of pre-fillable syringe cannulas and needle shields, taking place…
Read More...
Previous 1 … 477 478 479 480 481 … 957 Next
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
10th IPF Summit
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
17th World ADC London
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
17th World ADC San Diego
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
  • CSL, Alentis Partner on $1.55B Kidney and Liver Drug
  • Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
  • KymaThera Raises $80M to Advance PI3Kα Cancer Drug
  • Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

AI, Structure Prediction and Advanced Computational Tools…

New Preclinical Data and Translational Advances Set to Take…

FDA, Health Canada & Leading Biopharma Organizations…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.